Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.24.3
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Jul. 31, 2024
Jul. 31, 2023
Revenues $ 31,907 $ 31,061
Operating costs, expenses and legal settlements, net:    
Cost of revenues 17,275 17,866
Research and development 2,642 3,904
Selling, general, and administrative 21,723 27,202
Legal and related expenses 2,632 5,196
Total costs and expenses, net 44,272 55,797
Operating loss (12,365) (24,736)
Other income (expense):    
Interest income 3,538 277
Interest expense (197) (1,399)
Change in fair value of convertible debentures (1,095) (824)
Other 494 380
Foreign exchange (loss) gain (192) 1,280
Loss before income taxes (9,817) (25,022)
Income taxes
Net loss from continuing operations (9,817) (25,022)
Net loss from discontinued operations (16,261) (37,321)
Gain on sale of discontinued operations, net of tax 82,631
Net (loss) income $ (26,078) $ 20,288
Net (loss) income per common share – basic and diluted:    
Continuing operations. basic (in Dollars per share) $ (0.19) $ (0.51)
Continuing operations, diluted (in Dollars per share) (0.19) (0.51)
Discontinued operations, basic (in Dollars per share) (0.32) 0.92
Discontinued operations, diluted (in Dollars per share) (0.32) 0.92
Total net (loss) income per basic common share (in Dollars per share) (0.51) 0.41
Total net income (loss) per diluted common share (in Dollars per share) $ (0.51) $ 0.41
Weighted average common shares outstanding:    
Basic (in Shares) 50,902 49,160
Diluted (in Shares) 50,902 49,160
Inventory Provision    
Operating costs, expenses and legal settlements, net:    
Cost of revenues $ 1,629